ADMA Biologics, Inc. (ADMA) is a Healthcare company in the Biotechnology industry. It has a market capitalization of $2.22B, a trailing price-to-earnings ratio of 13.8 and a free-cash-flow yield of 1.1%. Over the most recent reported fiscal year, revenue grew 19.6% and free cash flow per share fell 75.2%.